EnteroMedics (NSDQ:ETRM) said it named Dan Gladney, the former chief executive who led Lanx to an acquisition by Biomet, to be its new CEO effective Nov. 16. St. Paul, Minn.-based EnteroMedics said chairman, president & CEO Mark Knudson will become executive chairman when Gladney takes over the corner office until Jan. 1, 2016, when he will […]
Siemens (NYSE:SI) said it lured Abbott (NYSE:ABT) executive David Pacitti to lead its North American Healthcare business, succeeding Dr. Gregory Sorensen. Siemens Healthcare made Pacitti, whose resume includes a 14-year spell at Guidant, president of Siemens Medical Solutions USA and head of its North America regional organization effective Oct. 19. “David Pacitti’s leadership experience at Abbott […]
Minnesota medical device maker Conventus Orthopaedics is swapping some executives, naming a new chief executive officer and new chief commercial officer in one fell swoop.
The orthopedics company appointed as its new CEO Paul Buckman, who brought with him years of medtech experience at companies including Boston Scientific and St. Jude Medical. Buckman also co-founded ev3, which Covidien acquired in 2010 for $2.6 billion. Buckman has also served on Conventus’ board of directors since 2009.
San Diego-based NuVasive, which makes spinal surgery implants, said 3rd-quarter sales will be about $147 million, 4.8% below the roughly $154.4 million the company expected to post.
Buyout chatter pushed shares of Shire plc (FTSE:SHP) up nearly 2% in London yesterday and added 1.4% on Wall Street.
Wall Street investors drove Insulet (NSDQ:PODD) shares up nearly 4% today ahead of the insulin management company’s 4th-quarter and full-year earnings statement.
Bedford, Mass.-based Insulet posted losses of $14.3 million, or 30 cents per share, on sales of $47.2 million for the 3 months ended Dec. 31, 2011, adding 70% to the top line and shaving 31.3 percent off of its losses, compared with the same period in 2010.
Vascular Solutions Inc. (NSDQ:VASC) paid $5.75 million for a pair of vein-access technologies used in ultrasound procedures.
The Minneapolis-based company expects the new products to begin paying immediate dividends and upped its full-year sales guidance by $2 million.